Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
January 17, 2017
Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial
Jonathan G Hiller, Shienny Sampurno, Rosemary Millen, et al.
Journal of Visualized Experiments : Jove
|
May 17, 2021
Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids
Marrit Putker, Rosemary Millen, René Overmeer, et al.
Human Vaccines & Immunotherapeutics
|
February 24, 2018
Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine
Maria Bolther, Karen Lise Dahl Andersen, Martin Tolstrup, et al.
Hemasphere
|
August 28, 2024
Long-term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab
Arnon P Kater, Barbara F Eichhorst, Carolyn J Owen, et al.
Oncoimmunology
|
September 14, 2016
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer
Rosemary Millen, Jordane Malaterre, Ryan S Cross, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2024
Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7
Matteo Boretto, Maarten H Geurts, Shashank Gandhi, et al.
Clinical & Translational Immunology
|
September 21, 2020
CD8<sup>+</sup> tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous <i>de novo</i> metastatic colorectal carcinoma do not track with survival
Rosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
Blood
|
February 26, 2025
The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL
Arnon P Kater, Rosemary Anne Harrup, Thomas J Kipps, et al.
Med (New York, N.Y.)
|
May 13, 2023
Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
Rosemary Millen, Willem W B De Kort, Mandy Koomen, et al.
Nature Immunology
|
November 27, 2023
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
Patricia Hernández-López, Eline van Diest, Peter Brazda, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
January 17, 2017
Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial
Jonathan G Hiller, Shienny Sampurno, Rosemary Millen, et al.
Journal of Visualized Experiments : Jove
|
May 17, 2021
Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids
Marrit Putker, Rosemary Millen, René Overmeer, et al.
Human Vaccines & Immunotherapeutics
|
February 24, 2018
Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine
Maria Bolther, Karen Lise Dahl Andersen, Martin Tolstrup, et al.
Hemasphere
|
August 28, 2024
Long-term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab
Arnon P Kater, Barbara F Eichhorst, Carolyn J Owen, et al.
Oncoimmunology
|
September 14, 2016
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer
Rosemary Millen, Jordane Malaterre, Ryan S Cross, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2024
Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7
Matteo Boretto, Maarten H Geurts, Shashank Gandhi, et al.
Clinical & Translational Immunology
|
September 21, 2020
CD8<sup>+</sup> tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous <i>de novo</i> metastatic colorectal carcinoma do not track with survival
Rosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
Blood
|
February 26, 2025
The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL
Arnon P Kater, Rosemary Anne Harrup, Thomas J Kipps, et al.
Med (New York, N.Y.)
|
May 13, 2023
Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
Rosemary Millen, Willem W B De Kort, Mandy Koomen, et al.
Nature Immunology
|
November 27, 2023
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
Patricia Hernández-López, Eline van Diest, Peter Brazda, et al.
Page
of 2